Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

MAB1910

Sigma-Aldrich

Anti-Collagen Type IV α 2 Chain Antibody, clone 23IIC3

ascites fluid, clone 23IIC3, Chemicon®

Synonym(e):

Anti-BSVD2, Anti-ICH, Anti-POREN2

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

Biologische Quelle

mouse

Qualitätsniveau

Antikörperform

ascites fluid

Antikörper-Produkttyp

primary antibodies

Klon

23IIC3, monoclonal

Speziesreaktivität

monkey, human, rat

Hersteller/Markenname

Chemicon®

Methode(n)

ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable

Isotyp

IgG1

UniProt-Hinterlegungsnummer

Versandbedingung

dry ice

Posttranslationale Modifikation Target

unmodified

Angaben zum Gen

human ... COL4A2(1284)

Spezifität

Recognizes Human type IV collagen, alpha-2 chains.

Immunogen

Human amniotic type IV collagen

Anwendung

Research Category
Zellstruktur
Research Sub Category
ECM-Proteine
Detect Collagen Type IV α 2 Chain using this Anti-Collagen Type IV α 2 Chain Antibody, clone 23IIC3 validated for use in ELISA, IH(P) & WB.
Immunohistochemistry: 1:500, acetone fixed, frozen tissue recommended. Weak reactivity on on formalin fixed, paraffin sections (1:100) after treatment with 1% trypsin (20 minutes, room temperature). Or alternatively, 4% PFA fixed, HEIR treated tissue has worked in monkey (Qin, 2003) at 1:200 dilution.

Western blot: 1:500, 170 kDa.

ELISA at 1:200

Optimal working dilutions must be determined by the end user.

Zielbeschreibung

170 kDa

Physikalische Form

Unpurified
Liquid.

Lagerung und Haltbarkeit

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Hinweis zur Analyse

Control
Positive Control: Kidney, muscle, tendon spleen tissue
Negative Control: Neurons/glia

Sonstige Hinweise

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Rechtliche Hinweise

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sie haben nicht das passende Produkt gefunden?  

Probieren Sie unser Produkt-Auswahlhilfe. aus.

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Immunolocalization of tight junction proteins in blood vessels in human germinal matrix and cortex.
John A Anstrom,Clara R Thore,Dixon M Moody,William R Brown
Histochemistry and Cell Biology null
Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.
Manigrasso, MB; Sawyer, RT; Hutchens, ZM; Flynn, ER; Maric-Bilkan, C
American Journal of Physiology: Renal Physiology null
Laminin-5-enriched extracellular matrix accelerates angiogenesis and neovascularization in association with ePTFE.
Kameha R Kidd, Stuart K Williams
Journal of Biomedical Materials Research Part A null
D Ohlund et al.
British journal of cancer, 101(1), 91-97 (2009-06-06)
Pancreas cancer is a dreaded disease with high mortality, despite progress in surgical and oncological treatments in recent years. The field is hampered by a lack of good prognostic and predictive tumour biomarkers to be used during follow-up of patients.
Reduced ratio of afferent to total vascular density in mesial temporal sclerosis.
Mott RT, Thore CR, Moody DM, Glazier SS, Ellis TL, Brown WR
Journal of Neuropathology and Experimental Neurology null

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.